Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02249065
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:33.230538+00:00
Published At
2017-10-19T00:00:00+00:00
Record Updated At
2022-08-01
Results Posted At
2017-10-19
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Rosacea"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-08-01"
protocolSection.identificationModule.nctId
"NCT02249065"
protocolSection.identificationModule.officialTitle
"MIRVASO\u00ae In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2017-10-19"

Study condition terms

  • Rosacea (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.